In conclusion, our study demonstrates increased levels of AT1R and ETAR autoantibodies in COVID19 patients who were admitted to intensive care and/or died during hospital stay, compared to patients with a favorable COVID19 outcome. Here, AGTR1 is linked to COVID-19.